Residual abdominal lymphadenopathy after intensive frontline chemoimmunotherapy is associated with inferior outcome independently of minimal residual disease status in chronic lymphocytic leukemia - Fürstenau, Moritz; Bahlo, J.; Fink, A. M.; Lange, E.; Dreger, Peter; Dreyling, M.; Hess, G.; Ritgen, M.; Kneba, M.; Döhner, H.; Stilgenbauer, S.; Wendtner, C. M.; et al. (Leukemia, 2020)
Published online: 14 October 2019
Gesehen am 16.04.2020